XML 34 R16.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Common Stock and Options | 12 Months Ended
--- | ---
Sep. 30, 2017
Equity [Abstract] |
Common Stock and Options | Common Stock and Options Effective January 27, 2015, the Company’s Board of Directors adopted the 2015 Stock Incentive Plan (the “2015 Plan”) which provides for up to an additional 1,250,000 common shares available for issuance to provide a long-term incentive plan for officers, employees, directors and/or consultants to directly link incentives to stockholder value. The 2015 Plan was approved by the Company’s stockholders in February 2015. The Company’s 2015 Plan provides for grants to executives in various forms including restricted shares of the Company’s common stock and stock options. Awards are discretionary and are determined by the Compensation Committee of the Board of Directors. Awards vest based upon service conditions. Non-vested restricted shares generally vest over requisite service periods of one to six years from the date of grant. Restricted Stock In fiscal year 2015, the Company awarded 12,500 restricted shares of the Company’s common stock (“Restricted Stock”) to two senior executives under the 2015 Plan at a weighted average fair value of $49.49 per common share, vesting over three to five years. A summary of the status of the Company’s nonvested shares is as follows:
Nonvested Shares |  | Shares |  |  | Weighted-Average Grant Date Fair Value |
Nonvested Shares at September 30, 2014 |  | — |  |  | — |
Granted during fiscal 2015 |  | 12,500 |  |  | $ | 49.49 |
Vested during 2015 fiscal |  | — |  |  | — |
Forfeited during fiscal 2015 |  | — |  |  | — |
Nonvested Shares at September 30, 2015 |  | 12,500 |  |  | $ | 49.49 |
Granted during fiscal 2016 |  | — |  |  | — |
Vested during 2016 fiscal |  | (2,333 | ) |  | $ | 49.50 |
Forfeited during fiscal 2016 |  | — |  |  | — |
Nonvested Shares at September 30, 2016 |  | 10,267 |  |  | $ | 49.49 |
Granted during fiscal 2017 |  | — |  |  | — |
Vested during fiscal 2017 |  | (4,933 | ) |  | $ | 49.58 |
Forfeited during fiscal 2017 |  | — |  |  | — |
Nonvested Shares at September 30, 2017 |  | 5,334 |  |  | $ | 49.39 |
Stock compensation expense related to the Restricted Stock totaled approximately $264,000 and $150,000 for the fiscal year ended September 30, 2017 and 2016, respectively. There was approximately $149,000 and $413,000 of total unrecognized stock compensation costs related to nonvested stock compensation for the Restricted Stock grants at September 30, 2017 and 2016, respectively. The unrecognized stock compensation will be fully expensed in fiscal year ended September 2018. Stock Options A stock option grant of 300,000 options in the case of Mr. Trafelet and 225,000 options in the case of each of Messrs. Slack and Brokaw (collectively, the “Option Grants”) were granted on December 31, 2016. The option price was set at $27.15, the closing price on December 31, 2016. The Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $60.00; (ii) 25% of the options will vest if such price exceeds $75.00; (iii) 25% of the options will vest if such price exceeds $90.00; and (iv) 25% of the options will vest if such price exceeds $105.00. If the applicable stock price hurdles have not been achieved by (A) the second anniversary of the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by the fifth anniversary of the grant date (or the fourth anniversary of the grant date, in the case of the tranche described in clause (i) above), then any unvested options will be forfeited. The Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of September 30, 2017, the Company’s stock was trading at $34.15 per share and during fiscal 2017 the stock did not trade above $34.45 per share; accordingly, none of the stock options are vested at September 30, 2017.
|  | Number of Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value
Balance - September 30, 2016 |  | — |  |  | — |  |  | — |  |  | — |
Granted during fiscal 2017 |  | 750,000 |  |  | $ | 3.53 |  |  | 3.33 |  |  | — |
Forfeitures/expired in fiscal 2017 |  | — |  |  | — |  |  | — |  |  | — |
Exercised during fiscal 2017 |  | — |  |  | — |  |  | — |  |  | — |
Balance - September 30, 2017 |  | 750,000 |  |  | $ | 3.53 |  |  | 2.58 |  |  | — |
Stock compensation expense related to the options totaled approximately $616,000 for the fiscal year ended September 30, 2017. No stock compensation expense related to options was recorded for the fiscal year ended September 30, 2016. At September 30, 2017 there was approximately $2,030,000 to total unrecognized stock compensation costs related to nonvested share-based compensation for the option grants. The fair value of the Option Grants was estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the following table. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from different time-frames for the various market conditions being met.
Expected Volatility | 32.19 | %
Expected Term (in years) | 2.6 - 4.0 |
Risk Free Rate | 2.45 | %
The weighted-average grant-date fair value of the Option Grants was $3.53. There were no additional stock options granted, exercised or forfeited for the fiscal year ended September 30, 2017. As of September 30, 2017, there were 487,500 common shares available for issuance under the 2015 Plan.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration